Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 429

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

Open access
Schwarz, Christopher G., Gunter, Jeffrey L., Wiste, Heather J., Przybelski, Scott A., Weigand, Stephen D., Ward, Chadwick P., Senjem, Matthew L., Vemuri, Prashanthi, Murray, Melissa E., Dickson, Dennis W., Parisi, Joseph E., Kantarci, Kejal, Weiner, Michael W., Petersen, Ronald C., Jack, Clifford R.·2016·NeuroImage: Clinical

Abstract

Alzheimer's disease (AD) researchers commonly use MRI as a quantitative measure of disease severity. Historically, hippocampal volume has been favored. Recently, "AD signature" measurements of gray matter (GM) volumes or cortical thicknesses have gained attention. Here, we systematically evaluate multiple thickness- and volume-based candidate-methods side-by-side, built using the popular FreeSurfer, SPM, and ANTs packages, according to the following criteria: (a) ability to separate clinically normal individuals from those with AD; (b) (extent of) correlation with head size, a nuisance covariatel (c) reliability on repeated scans; and (d) correlation with Braak neurofibrillary tangle stage in a group with autopsy. We show that volume- and thickness-based measures generally perform similarly for separating clinically normal from AD populations, and in correlation with Braak neurofibrillary tangle stage at autopsy. Volume-based measures are generally more reliable than thickness measures. As expected, volume measures are highly correlated with head size, while thickness measures are generally not. Because approaches to statistically correcting volumes for head size vary and may be inadequate to deal with this underlying confound, and because our goal is to determine a measure which can be used to examine age and sex effects in a cohort across a large age range, we thus recommend thickness-based measures. Ultimately, based on these criteria and additional practical considerations of run-time and failure rates, we recommend an AD signature measure formed from a composite of thickness measurements in the entorhinal, fusiform, parahippocampal, mid-temporal, inferior-temporal, and angular gyrus ROIs using ANTs with input segmentations from SPM12.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nicl.2016.05.017

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Research works printed but not linked: 1

  1. Das, 2007, Measuring cortical thickness using an image domain local surface model and topology preserving segmentation, Comput. Vision Int. Conf.

Cited by

See all 429

Metadata

Authors
Schwarz, C. G., Gunter, J. L., Wiste, H. J., Przybelski, S. A., Weigand, S. D., Ward, C. P., Senjem, M. L., Vemuri, P., Murray, M. E., Dickson, D. W., Parisi, J. E., Kantarci, K., Weiner, M. W., Petersen, R. C., & Jack, C. R.
Venue
NeuroImage: Clinical
Publisher
Elsevier BV
Published
2016
Volume
11
Pages
802-812
ISSN
2213-1582 (ISSN-L)
OpenAlex
W2460653397
Cited by
429
References
75
FWCI
14.75
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • The Alexander Family Professorship of Alzheimer's Disease Research, Mayo Clinic; the GHR Foundation (R01-AG040042, R01-AG011378, R00-AG37573, P50-AG16574/P1, R01-AG041851, U01-AG24904, U01-AG06786, P50-AG16574, R01-AG034676)
  • Alzheimer's Disease Neuroimaging Initiative
  • National Institutes of Health (U01 AG024904)
  • DOD ADNI
  • Department of Defense (W81XWH-12-2-0012)
  • National Institute on Aging
  • National Institute of Biomedical Imaging and Bioengineering
  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Drug Discovery Foundation
  • Araclon Biotech
  • BioClinica, Inc.
  • Biogen
  • Bristol-Myers Squibb Company
  • CereSpir, Inc.
  • Eisai Inc.
  • Elan Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • EuroImmun
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • Fujirebio
  • GE Healthcare
  • IXICO Ltd.
  • Janssen Alzheimer Immunotherapy Research & Development, LLC.
  • Johnson & Johnson Pharmaceutical Research & Development LLC.
  • Lumosity
  • Lundbeck
  • Merck & Co., Inc.
  • Meso Scale Diagnostics, LLC.
  • NeuroRx Research
  • Neurotrack Technologies
  • Novartis Pharmaceuticals Corporation
  • Pfizer Inc.
  • Piramal Imaging; Servier
  • Takeda Pharmaceutical Company
  • Transition Therapeutics
  • Canadian Institutes of Health Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity. https://app.cochat.ai/papers/10.1016/j.nicl.2016.05.017
The paper
Schwarz, C. G., Gunter, J. L., Wiste, H. J., Przybelski, S. A., Weigand, S. D., Ward, C. P., Senjem, M. L., Vemuri, P., Murray, M. E., Dickson, D. W., Parisi, J. E., Kantarci, K., Weiner, M. W., Petersen, R. C., & Jack, C. R. (2016). A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity. NeuroImage: Clinical. https://doi.org/10.1016/j.nicl.2016.05.017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.